ダウンロード数: 184
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
26_0471.pdf | 6.55 MB | Adobe PDF | 見る/開く |
タイトル: | Anti-androgen剤の前立腺肥大症にたいする効果の病理組織学的研究 - TSAA-291投与前後の前立腺生検像の比較検討 - |
その他のタイトル: | A PATHIOHISTOLOGICAL STUDY ON THE EFFECTS OF AN ANTI-ANDROGEN, TSAA-291, ON BENIGN PROSTATIC HYPERPLASIA |
著者: | 友吉, 唯夫 岡田, 謙一郎 吉田, 修 沢田, 真治 川路, 尚徳 |
著者名の別形: | Tomoyoshi, Tadao Okada, Ken-ichiro Yoshida, Osamu Sawada, shinji Kawaji, Hisanori |
発行日: | Apr-1980 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 26 |
号: | 4 |
開始ページ: | 471 |
終了ページ: | 484 |
抄録: | TSAA-291, a new synthetic anti-androgen, was administered to 47 patients with benign prostatic hyperplasia for twelve weeks. The dosage per week was 200 mg in 7, 400 mg in 23 and 600 mg in 17 patients. The prostate was biopsied before and after the course of treatment. A committee was formed for histological evaluation of the prostate. Degenerative changes were evaluated according to the scoring method established by the committee. Histological improvement was proved in 43% of the 200 mg group, in 70% of the 400 mg group and 59% of the 600 mg group. The over-all effect was seen in 62%. Six cases which showed marked histological alterations were discussed in detail. Therapeutic effect of TSAA-291 on benign prostatic hyperplasia can be expected according to our pathohistological evaluation which was blindly performed. |
URI: | http://hdl.handle.net/2433/122622 |
出現コレクション: | Vol.26 No.4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。